Key Decision
The Board of Directors of TTK Healthcare Limited approved a Scheme of Arrangement between the Company and its Equity Shareholders under Section 230 and other applicable provisions of the Companies Act, 2013.
Scheme Details: Issuance of Non-Convertible Redeemable Preference Shares (NCRPS)
The Scheme involves the issuance and allotment of Non-Convertible Redeemable Preference Shares by way of bonus to the equity shareholders.
Instrument Details:
- Type: Non-Convertible Redeemable Preference Shares (NCRPS)
- Face Value: ₹100 per NCRPS
- Issue Price: ₹100 per NCRPS (at face value)
- Bonus Ratio: 5 NCRPS of ₹100 each for every 1 equity share of ₹10 each held on the Record Date (to be defined)
- Issue Size: 7,06,51,665 NCRPS amounting to ₹706.52 crores
- Dividend: 9.5% per annum
- Tenure: 15 months from the date of allotment
- Redemption: At par at the end of the tenure or at any time prior at the option of the Board of Directors
- Listing: Proposed to be listed on BSE Limited and the National Stock Exchange of India Limited (NSE)
Dividend Accrual Schedule:
- The first dividend shall accrue from the date of allotment up to 31st March of the financial year in which the shares are allotted.
- Thereafter, dividend shall accrue on 31st March of each financial year.
- In the financial year of redemption, dividend shall accrue proportionately from 1st April until the date of redemption and be payable with the redemption amount.
- No dividend accrues after the date of redemption.
Funding Source
The bonus issuance is proposed to be made by utilizing the company's general reserves and/or retained earnings.
Reserve Balances as of September 30, 2026 (Limited Reviewed):
- General Reserves: ₹78.48 crores
- Retained Earnings: ₹1,222.86 crores
An amount of approximately ₹706.52 crores will be utilized from these reserves for the bonus issue. The actual quantum will be determined based on the total outstanding equity share capital as on the Record Date.
Share Capital Impact
There will be no change to the existing equity share capital pursuant to this issuance.
Current Share Capital (as of November 20, 2026):
- Authorized Share Capital: 2,00,00,000 Equity Shares of ₹10 each (₹20,00,00,000)
- Issued, Subscribed and Paid-up Capital: 1,41,30,333 Equity Shares of ₹10 each (₹14,13,03,330)
Post-Bonus Issue Share Capital (based on November 20, 2026 figures):
- Authorized Share Capital will be increased to accommodate NCRPS: 2,00,00,000 Equity Shares of ₹10 each + 7,30,00,000 NCRPS of ₹100 each (Total: ₹7,50,00,00,000)
- Issued, Subscribed and Paid-up Capital: 1,41,30,333 Equity Shares of ₹10 each + 7,06,51,665 NCRPS of ₹100 each (Total: ₹7,20,64,69,830)
Approvals Required
The Scheme is subject to receipt of statutory, regulatory and customary approvals, including approvals from:
- Stock Exchanges (BSE and NSE)
- Jurisdictional National Company Law Tribunal (NCLT)
- Shareholders of the Company
- Creditors of the Company (as applicable)
Timeline
The bonus NCRPS will be allotted to shareholders as on the Record Date after obtaining the approval of the NCLT pursuant to the Scheme. No estimated date for credit/dispatch is provided.
Additional Information
The Scheme as approved by the Board would be made available on the company's website at www.ttkhealthcare.com after submitting it to the Stock Exchanges.
The disclosure is made in terms of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.